Full-Time

Regulatory Affairs Manager

Data Management

Posted on 3/24/2025

AstraZeneca

AstraZeneca

10,001+ employees

Develops and commercializes prescription medicines

No salary listed

Senior, Expert

Sant Cugat del Vallès, Barcelona, Spain

3 days at office/3 days at home

Category
Data Management
Legal & Compliance
Data & Analytics
Requirements
  • Relevant University Degree in Science or related discipline or equivalent relevant regulatory experience within the biopharmaceutical industry, or at a health authority, or other relevant experience
  • General knowledge of drug development
  • Strong project management skills
  • Leadership skills
  • Stakeholder management skills
Responsibilities
  • Point of contact for questions and feedback, providing consistent and dedicated support for technical matters and issues
  • Coaches, mentors, and holds regulatory team responsible for data entry
  • Owns short training videos, frequently asked questions (FAQ) document, and guides for hints and tips on using PORT
  • Supports GRETs in providing visualization of the submission delivery plans, agency interactions, and other regulatory visualization as needed
  • Organizes and facilitates trainings and awareness
  • Supports APOLLO roll-out once linked with PORT and other systems
  • Actively promotes the use of PORT within ORSS
  • Shows efficient approach in embedding PORT in ways of working
  • Employs excellent communication skills, with the ability to build effective and collaborative working relationships with RAM group members for data entry and updates to time and quality
  • Performs data quality checks via Data Quality Dashboard and coordinates and communicates outcomes from other regular PORT data checks and follows-up
  • Keeps Regulatory up-to-date with changes in PORT via preparing communications and posting in Workplace or equivalent
  • Owns creation of general inbox, Workplace, and SPOL
  • Organizes and facilitates collaboration with IT, if required
  • Works closely with LRPMs, RAMs, and RADs if required, to identify blockers or issues for maintaining and using PORT, and opportunities for improving via escalation to LRPMs and PORT team, as appropriate
  • Maintains a list of PORT development and enhancement recommendations (logging and tracking)
  • Contributes to process improvement activities across the RAM group, where PORT or other tools can offer a digital solution or provide benefit
  • Supports PORT team in establishing and troubleshooting PORT Access/Security levels within ORSS
  • Point of Contact for PORT User Access requests
  • Active member of PORT team and pro-active expert in data management for PORT
  • Provides administrative support for PORT team (e.g., PORT Team general email [PORT Support Team], maintenance of PORT workplace, maintenance of PORT landing page (SharePoint, Nucleus or equivalent), etc)
Desired Qualifications
  • Regulatory experience with a focus on delivery and execution
  • Understanding of regulatory deliverables at the project level
  • Knowledge of AZ Business, processes, and systems

AstraZeneca focuses on discovering, developing, and selling prescription medicines. The company specializes in three main areas: Oncology, which deals with cancer treatments; Cardiovascular, Renal & Metabolism, which addresses heart, kidney, and metabolic diseases; and Respiratory & Immunology, which targets lung and immune system diseases. Their products are developed through extensive research and development, followed by clinical trials and regulatory approvals before they reach the market. AstraZeneca differentiates itself from competitors by investing heavily in scientific research and forming strategic partnerships to enhance drug discovery. Their goal is to advance healthcare by creating effective treatments for serious diseases and collaborating with other organizations to improve their research capabilities.

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery enhances AstraZeneca's R&D efficiency and innovation.
  • Real-world evidence supports AstraZeneca's drug efficacy and safety demonstrations.
  • Personalized medicine aligns with AstraZeneca's focus on precision oncology treatments.

What critics are saying

  • Class-action lawsuit over Soliris could lead to financial penalties and reputational damage.
  • AI tool for breast cancer screening may face challenges due to minority underrepresentation.
  • Investment in Dunkirk production lines may be affected by changes in French regulations.

What makes AstraZeneca unique

  • AstraZeneca excels in oncology, cardiovascular, and respiratory therapeutic areas.
  • The A.Catalyst Network fosters global collaboration and innovation in healthcare.
  • Open Innovation program accelerates drug discovery by sharing resources with the scientific community.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

Life Sciences IP Review
Apr 17th, 2025
AstraZeneca unit faces class-action suit over alleged Soliris monopoly

AstraZeneca unit faces class-action suit over alleged soliris monopoly.

Our Health Needs
Apr 11th, 2025
Study: Racial, ethnic minorities are underrepresented in AI mammogram interpretation

In 2024, AI biotech company Owkin partnered with pharma giant AstraZeneca to develop an AI-powered tool designed to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides.

Medical Update Online
Apr 11th, 2025
AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025

AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025.

Cision
Apr 11th, 2025
Result Of Agm

11 April 2025Results of Annual General Meeting held on 11 April 2025AstraZeneca PLC announced the results of the voting at its Annual General Meeting (AGM) today. As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 9 - 12 were passed as special resolutions; all other resolutions were passed as ordinary resolutions.Resolution. Votes for. % of votes cast

Europawire
Apr 8th, 2025
AstraZeneca Unveils Breakthrough Data on Vaccines and Antibody Therapies for Infections

AstraZeneca unveils breakthrough data on vaccines and antibody therapies for infections.

INACTIVE